Session RED |
|
Integration of Chemical Information |
|
| Accelerating problem solving and decision making in medicinal chemistry through visualisation Paul Hawkins |
P‑01 |
| Nanomaterial safety data integration with substance data model and federated search Nina Jeliazkova |
P‑03 |
| Can we agree on the structure represented by a SMILES string? A benchmark dataset Noel M O'Boyle |
P‑05 |
Structure-Activity and Structure-Property Prediction |
|
| Computational Studies of Integrin Inhibitors Saleh Saeed Alarfaji, The University of Nottingham |
P‑07 |
| Fast prediction of the specific conductivity of electrolytes from the molecular structure of the solvent Rémi Bouteloup |
P‑09 |
| Identification of novel sodium-dependent glucose co-transporter 1 inhibitors using proteochemometrics Lindsey Burggraaff |
P‑11 |
| Application of 3D-QSAR Methods in Drug Design & Discovery: Two Case Studies Giulia Chemi |
P‑13 |
| Applications of in silico approaches to decipher the structure and functions of ADAMTS13: En route to novel therapeutics of TTP Bogac Ercig, Maastricht University |
P‑15 |
| Confidence estimation of ADME properties using conformal prediction Christina Maria Founti, The University of Sheffield |
P‑17 |
| Selectivity profiles in Activity Atlas Mark Mackey, Cresset |
P‑19 |
| KnowTox: Risk Assessment by Automated Read-Across and Machine Learning Andrea Morger, Charite Berlin |
P‑21 |
| Machine learning to predict the recruitment profile of intracellular binding partners of G protein-coupled receptors Trung Ngoc Nguyen, Freie Universität Berlin |
P‑23 |
| Estimation of electrophilicity for warheads of covalent protease inhibitors Szymon Pach, Freie Universität Berlin |
P‑25 |
| A web-based informatics platform for PhysChem/ADME/Tox property predictions Andrius Sazonovas, ACD/Labs, Inc. |
P‑27 |
| Development of a novel structure descriptor combining molecular shape and surface properties Anke Schultz, Technische Universität Braunschweig |
P‑29 |
| Classification of corneal permeability of drug-like compounds using data mining and machine learning Carlos J. V. Simões |
P‑31 |
| Coarse-grained approaches for prediction of solubility and membrane permeability of large drugs: The Why and the How Teun Sweere, Culgi BV and Leiden University |
P‑33 |
| Molecular Dynamics Fingerprints (MDFP): Combining MD and Machine Learning to Predict Physicochemical Properties Shuzhe Wang |
P‑35 |
Structure-Based Drug Design and Virtual Screening |
|
| Towards Small Molecule Inhibition of HSP90 Dimerization David Bickel, Heinrich Heine University Duesseldorf |
P‑37 |
| Reverse Virtual Screening Procedure for Identifying the Target of an Antiplasmodial Hit Compound Simone Brogi |
P‑39 |
| Conformational Sampling and Binding Affinity Prediction of Macrocycles Daniel Cappel |
P‑41 |
| Using FEP (Free Energy Perturbation) Calculations to estimate relative binding affinities and selectivity for GPCR targets Francesca Deflorian, Heptares Therapeutics Ltd |
P‑43 |
| Can I Have Seconds? Christiane Ehrt, TU Dortmund University |
P‑45 |
| Virtual Screening of CCR5 Inhibitors as Potential Anti- Colorectal Cancer Agents Mariam El-Zohairy, Faculty of Pharmacy and Biotechnology at the German University in Cairo |
P‑47 |
| SILCS reproduces experimental binding trends for 31 TrmD ligands Olgun Guvench, SilcsBio |
P‑49 |
| Fuzzy ligands for allosteric target detection and lead identification Susanne Hermans, Heinrich-Heine University, Düsseldorf |
P‑51 |
| A fast and efficient rescoring method based on binding information of fragment and drug-like ligands Célien Jacquemard, Université de Strasbourg |
P‑53 |
| Mapping Binding Site Thermodynamics by 3D RISM Theory for Drug Design Julia Beatrice Jasper, TU Dortmund |
P‑55 |
| Structure based design of potent and selective ligands for the adenosine receptor family Willem Jespers |
P‑57 |
| Transferable Neural Networks Architecture for Low Data Drug Discovery Mun-Hwan Lee, Seoul University |
P‑59 |
| Tetris of HDAC Inhibitor Design Jelena Melesina, Martin Luther University Halle-Wittenberg |
P‑61 |
| Applications of Binding Free Energy Calculations and QSAR Modeling to Design Novel Inhibitors for Human Myt1 Kinase Abdulkarim Najjar |
P‑63 |
| Estimation of solvation free energies by continuum methods: How to tackle halogenated species? Rafael Nunes |
P‑65 |
| A multi-target approach to neurodegenerative diseases Sebastian Oddsson, University of Iceland |
P‑67 |
| A Computational Platform For Fragment Evolution Serena Gaetana Piticchio, University of Barcelona |
P‑69 |
| NAOMInext - Reaction-Driven Probing of Protein Binding Sites Kai Sommer |
P‑71 |
| Effects of MD-MM/GBSA Parameters on the Rank-Ordering of Ligands in Drug Design Nikolaus Stiefl, Novartis Institute of Biomedical Research |
P‑73 |
| Can I make this into a macrocycle? Effective methods for fragment growing, joining and cyclisation. Paolo Tosco, Cresset |
P‑75 |
| Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces Andrea Volkamer, Charité – Universitätsmedizin Berlin |
P‑77 |
Session BLUE |
|
Analysis of Large Chemical Data Sets |
|
| Characterization of the Chemical Space of Known and of Readily Purchasable Natural Products Ya Chen, University of Hamburg |
P‑02 |
| Effects of missing data on multitask prediction performance Antonio de la Vega de Leon |
P‑04 |
| Compound enumeration using Reaction Workflows Jameed Hussain, Dotmatics |
P‑06 |
| chem2vec : vector embedding of atoms and molecules Nina Jeliazkova |
P‑08 |
| Building and searching large chemistry spaces Uta Lessel, Boehringer Ingelheim Pharma GmbH & Co. KG |
P‑10 |
| Learning from Extant Medicinal Chemistry to Accelerate Hit Identification and Optimisation in Drug Discovery Yi Mok, The Institute of Cancer Research |
P‑12 |
| HTS workup at AZ – state of the art Willem Nissink |
P‑14 |
| A Comprehensive Evaluation of ACD/LogD on a Pharmaceutical Compound Set Andrius Sazonovas, ACD/Labs, Inc. |
P‑16 |
| Halogens in protein-ligand binding mechanism: a structural perspective Nicolas Ken Shinada, Discngine |
P‑18 |
| Interoperable and scalable data analysis in metabolomics Christoph Steinbeck, Friedrich-Schiller-University |
P‑20 |
| Supporting the assessment of the purging potential mutagenic impurities via analysis of patent literature Samuel Webb, Lhasa Limited |
P‑22 |
Dealing with Biological Complexity |
|
| Metabolite Structure Prediction Benefits from Cytochrome P450 Regioselectivity Prediction Christina de Bruyn Kops |
P‑24 |
| Small Molecule Binding Site Prediction - Know Your Needs Christiane Ehrt, TU Dortmund University |
P‑26 |
| Molecular nature of the increased activity of the Uridine 5’-diphospho-glucuronosyltransferase nine-fold mutant 1A5*8 David Machalz |
P‑28 |
| Searching within HELM Anne Mund, quattro research GmbH |
P‑30 |
| HELM-driven Integration of Peptides into Structure-Based Drug Design and Cheminformatics Conor Scully, Heptares Therapeutics |
P‑32 |
Cheminformatics |
|
| Machine Learning Models of Hydrogen Bond Basicity Based on Anisotropy Atomic Reactivity Descriptors Christoph Bauer, ETH Zürich |
P‑34 |
| International Chemical Identifier for Reactions (RInChI) Gerd Blanke, StructurePendium Technologies GmbH |
P‑36 |
| Characterizing Somatic Cancer Mutations in GPCRs Brandon Jeremy Bongers |
P‑38 |
| A Novel Approach to Assign Absolute Configuration Using Vibrational Circular Dichroism Lennard Böselt, ETHZ |
P‑40 |
| A Novel Search Engine and Application for Very Large Chemistry Database Mining Robert D Brown, Dotmatics |
P‑42 |
| Designing of a drug-like natural compound library for secondary metabolites collected from the African flora. Veranso Conrad Simoben |
P‑44 |
| mmpdb: A Matched Molecular Pair Platform for Large Multi-Property Datasets Andrew Dalke, Dalke Scientific Software |
P‑46 |
| 3D-e-Chem: Structural Cheminformatics Workflows for Computer-Aided Drug Discovery Chris de Graaf |
P‑48 |
| Analysis and inference within the molecular space: A visual approach using NAMS and multidimensional scaling Andre O. Falcao |
P‑50 |
| Reaction Classification by Reaction Vectors Gian Marco Ghiandoni, University of Sheffield |
P‑52 |
| Tautomeric Equilibria: Modeling and Visualization. Marta Glavatskikh, University of Strasbourg |
P‑54 |
| Artificial Intelligence in Medicinal Chemistry – Current Status at AstraZeneca Thierry Kogej, AstraZeneca |
P‑56 |
| Compact descriptor sets for automatic annotation of natural products in large databases by pairwise variable screening Max Kretzschmar, Technische Universität Braunschweig |
P‑58 |
| De novo drug-candidate molecule generation with generative adversarial networks Xuhan Liu |
P‑60 |
| The need for comprehensive reaction handling in SAVI and beyond Marc C. Nicklaus |
P‑62 |
| Flavours in Aromaticity Martin Ott, Lhasa Limited |
P‑64 |
| Smooth Molecular Surfaces with Joined Marching Cubes Thomas L. Sander, Idorsia Pharmaceutical Ltd. |
P‑66 |
| Chemistry Identifier Mapping to Pathway Databases using Ontologies: Expanding metabolomics analysis in WikiPathways with ChEBI Denise Nicole Smaragda Michelle Slenter |
P‑68 |
| Finding answers from chemical space extremely fast Akos Tarcsay, ChemAxon |
P‑70 |
| Structural Analysis of Protein Homomers – the Quest for Perfect Symmetry Inbal Tuvi-Arad, The Open University of Israel |
P‑72 |
| Wikidata and Scholia as a hub linking chemical knowledge Egon Willighagen |
P‑74 |
| PSMILES – A particle-based Molecular Structure Representation for Mesoscopic Simulation Achim Zielesny, Westphalian University of Applied Sciences |
P‑76 |
| A new, improved model to predict kinase inhibition Pieter FW Stouten, Galapagos NV |
P‑78 |